Back to today’s briefing

Story perspectives

U.S. Invests $590M in Moderna's H5N1 Vaccine Development

1/18/2025

23 4

Summary

Story summary

The U.S. government is pouring $590 million into Moderna to accelerate the creation of an mRNA vaccine for the H5N1 avian flu, responding to increasing infection rates. This investment builds on a total of $766 million in prior funding. Meanwhile, the CDC urges hospitals to swiftly identify H5N1 cases, assuring that the public's risk remains low.

1 of 1

Story summary

The U.S. government is pouring $590 million into Moderna to accelerate the creation of an mRNA vaccine for the H5N1 avian flu, responding to increasing infection rates. This investment builds on a total of $766 million in prior funding. Meanwhile, the CDC urges hospitals to swiftly identify H5N1 cases, assuring that the public's risk remains low.